ALLO
Allogene Therapeutics Inc
获取预测
在您的设备上获取AI股票预测
关于该公司
Allogene Therapeutics, Inc. is a biotechnology company that develops T-cell therapies using allogeneic chimeric antigen receptors for the treatment of blood cancers and solid tumors. Allogene Therapeutics serves patients in California.
立即获取AI股票预测
下载我们的AI股票预测实时应用
